Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 3,610.92 million compared to INR 3,641.33 million a year ago. Revenue was INR 3,702.54 million compared to INR 3,774 million a year ago. Net income was INR 395.73 million compared to INR 455.2 million a year ago. Basic earnings per share from continuing operations was INR 3.91 compared to INR 4.4 a year ago. Diluted earnings per share from continuing operations was INR 3.75 compared to INR 4.3 a year ago.